Fabio Chianelli
Chief Executive Officer bei PHARMATHER HOLDINGS LTD.
Vermögen: 5 Mio $ am 31.03.2024
Profil
Fabio Chianelli was the founder of Revive Therapeutics Ltd.
(founded in 2012) where he held the title of President & Director from 2016 to 2019.
Mr. Chianelli is also the founder of Revive Therapeutics, Inc...
Mr. Chianelli's current job(s) include being the Chief Executive Officer at Pharmather, Inc., Chairman & Chief Executive Officer at PharmaTher Holdings Ltd.
(since 2020), Chairman & Chief Executive Officer at DiagnaMed Holdings Corp.
(since 2021), and Owner of Fabiotech, Inc. Mr. Chianelli's former job includes being the Head-Investor Relations at Titan Medical, Inc. Mr. Chianelli's education history includes an undergraduate degree from Toronto Metropolitan University of.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PHARMATHER HOLDINGS LTD
17,58% | 30.11.2023 | 15 498 500 ( 17,58% ) | 4 Mio $ | 31.03.2024 |
DIAGNAMED HOLDINGS CORP.
9,20% | 25.04.2024 | 7 366 647 ( 9,20% ) | 265 199 $ | 31.03.2024 |
Aktive Positionen von Fabio Chianelli
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARMATHER HOLDINGS LTD. | Chief Executive Officer | 01.01.2020 |
| DIAGNAMED HOLDINGS CORP. | Chief Executive Officer | 11.08.2021 |
Fabiotech, Inc.
 Fabiotech, Inc. Advertising/Marketing ServicesCommercial Services Fabiotech, Inc. provides outdoor advertising services. The private company is based in Woodbridge, Canada and was founded in 2004. | Corporate Officer/Principal | - |
Revive Therapeutics, Inc.
 Revive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Revive Therapeutics Ltd., Revive Therapeutics, Inc. is a specialty life sciences company based in North York, CA. The private company focuses on the research and development of therapeutics for rare disorders and infectious diseases. Revive Therapeutics' cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. Revive Therapeutics was acquired by Mercury Capital II Ltd. on January 06, 2014 for $4.67 million. The Canadian company was granted FDA orphan drug status designation for the use of CBD to treat auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is also exploring the use of bucillamine for the potential treatment of infectious diseases, including COVID-19. The company was founded by Fabio Chianelli. Revive recently acquired Psilocin Pharma Corp. to advance psilocybin-based therapeutics in various diseases and disorders. | Founder | - |
Pharmather, Inc.
 Pharmather, Inc. Pharmaceuticals: MajorHealth Technology Pharmather, Inc. operates as a pharmaceutical company. The firm focuses on drug repurposing with artificial intelligence. The company is headquartered in Toronto, Canada. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Fabio Chianelli
| Unternehmen | Position | Ende |
|---|---|---|
| REVIVE THERAPEUTICS LTD. | Founder | 18.12.2019 |
| TITAN MEDICAL INC. | Investor Relations Contact | - |
Ausbildung von Fabio Chianelli
| Toronto Metropolitan University of | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| TITAN MEDICAL INC. | Health Technology |
| REVIVE THERAPEUTICS LTD. | Health Technology |
| PHARMATHER HOLDINGS LTD. | Health Technology |
| DIAGNAMED HOLDINGS CORP. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Revive Therapeutics, Inc.
Revive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Revive Therapeutics Ltd., Revive Therapeutics, Inc. is a specialty life sciences company based in North York, CA. The private company focuses on the research and development of therapeutics for rare disorders and infectious diseases. Revive Therapeutics' cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. Revive Therapeutics was acquired by Mercury Capital II Ltd. on January 06, 2014 for $4.67 million. The Canadian company was granted FDA orphan drug status designation for the use of CBD to treat auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is also exploring the use of bucillamine for the potential treatment of infectious diseases, including COVID-19. The company was founded by Fabio Chianelli. Revive recently acquired Psilocin Pharma Corp. to advance psilocybin-based therapeutics in various diseases and disorders. | Health Technology |
Fabiotech, Inc.
Fabiotech, Inc. Advertising/Marketing ServicesCommercial Services Fabiotech, Inc. provides outdoor advertising services. The private company is based in Woodbridge, Canada and was founded in 2004. | Commercial Services |
Pharmather, Inc.
Pharmather, Inc. Pharmaceuticals: MajorHealth Technology Pharmather, Inc. operates as a pharmaceutical company. The firm focuses on drug repurposing with artificial intelligence. The company is headquartered in Toronto, Canada. | Health Technology |
